HCW Biologics Inc.
NASDAQ: HCWB0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Hing C. Wong
- Employees
- 36
- Headquarters
- Miramar, United States
- IPO year
- 2021
- Market cap
- $2.3M
- Website
- https://www.hcwbiologics.com
Loading HCWB…
Loading profile data…Frequently asked questions about HCWB
What does HCW Biologics Inc. (HCWB) do?
HCW Biologics Inc. operates as a preclinical-stage biopharmaceutical firm, primarily engaged in the discovery and advancement of novel immunotherapies. Its research and development efforts are focused on addressing chronic, low-grade inflammation and a spectrum of age-related diseases. The company's leading therapeutic candidates include HCW9218...
Where does HCWB trade?
HCW Biologics Inc. (HCWB) trades on the NASDAQ Global Market.
What sector is HCWB in?
HCW Biologics Inc. (HCWB) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of HCW Biologics Inc.?
Hing C. Wong is the chief executive officer of HCW Biologics Inc. (HCWB).
Where is HCW Biologics Inc. headquartered?
HCW Biologics Inc. is headquartered in United States.
Does HCWB pay a dividend?
HCW Biologics Inc. (HCWB) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did HCWB go public?
HCW Biologics Inc. (HCWB) completed its initial public offering in 2021.